In The News: FDA Approves Genetically Modified Salmon; Pfizer and Allergan to Merge in $160 Billion Deal; NY Department of State Denies Critical Indian Point Certification;

FDA Approves Genetically Modified Salmon

Atlantic_salmon_Atlantic_fishJust last week, it has been approved by the Food and Drug Administration that Genetically Modified Salmon is perfectly fine to sell to the public WITHOUT a label. This is appalling. But don’t freak out just yet, because they still have 2 years in order for this frankenfish to hit grocery stores; meaning, we still have time to overthrow this outrageous new development. There are stores already openly stating that they will not be carrying GM salmon, so if we can get enough of these stores to opt out of this insane product, we can put GM salmon out of business before it even comes to be. Click here to find out more about how you can put a stop to GM salmon.

Pfizer and Allergan to Merge in $160 Billion DealPfizer_logo.svg

In some cases, bigger may be better, but this merger between corporate giant Pfizer and Ireland born Allergan does not equate to this saying. The deal is the latest — and the largest — to be aimed at helping an American company lower its taxes by re-incorporating overseas, a practice known as a corporate inversion. President Obama agrees at how completely un-American this action is, and has been working with the IRS to stop corporate inversions like this one. What does this mean for the American people? Well when two very large and very powerful companies combine, lots of things happen, like layoffs, lab productivity will worsen, important researches get fed up and leave, leading to low moral in the office and carelessness in research. Doesn’t sound like good news to me.

NY Department of State Denies Critical Indian Point Certification

Indian_Point_Nuclear_Power_PlantCiting numerous environmental and public safety concerns, the New York Department of State has filed an objection to Entergy’s request for a Coastal Consistency Determination for the Indian Point nuclear plant. This objection has the potential to block Entergy’s request for a 20-year extension of its operating license for the plant’s Unit 2 and Unit 3 reactors, and require the closure of Indian Point as soon as next year. This is great news for New York, since year after year there have been many mishaps at Indian Point leading to environmental disasters.